News & Updates
Filter by Specialty:
Progressive phenotype predicts transplantation-free survival in ILD, IPF patients
Nearly one in four nonidiopathic pulmonary fibrosis (non-IPF) patients with a fibrosing form of interstitial lung disease (FILD) develop a progressive phenotype relative to almost 60 percent of IPF patients, reveals a study. Survival of non-IPF FILD patients with such phenotype is similar to IPF.
Progressive phenotype predicts transplantation-free survival in ILD, IPF patients
02 May 2022
Listening to music eases anxiety during catheter placement
Patients undergoing venous catheter placements may benefit from listening to music, which significantly reduces their anxiety and stress levels, leading to a better overall experience, a recent study has found.
Listening to music eases anxiety during catheter placement
02 May 2022
Intravenous iron tied to low anaphylaxis risk
The rates of anaphylaxis among commonly used intravenous (IV) iron formulations are low, but those for iron dextran and ferumoxytol are three- to eightfold higher compared to iron sucrose, results of a recent study have shown.
Intravenous iron tied to low anaphylaxis risk
30 Apr 2022
Brigatinib a potential standard treatment alternative for treatment-naive ALK+ NSCLC
In patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer (ALK+ NSCLC) who were ALK inhibitor-naïve, brigatinib showed superior efficacy and safety over crizotinib, according to the final results of the phase III ALTA-1L* trial presented at ELCC 2022.